0000899243-23-006470.txt : 20230228 0000899243-23-006470.hdr.sgml : 20230228 20230228185735 ACCESSION NUMBER: 0000899243-23-006470 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230225 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Degnan Chris CENTRAL INDEX KEY: 0001741968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 23688605 MAIL ADDRESS: STREET 1: C/O VERRICA PHARMACEUTICALS INC. STREET 2: 10 NORTH HIGH STREET, SUITE 200 CITY: WEST CHESTER STATE: PA ZIP: 19380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-25 0 0001563577 Galera Therapeutics, Inc. GRTX 0001741968 Degnan Chris C/O GALERA THERAPEUTICS, INC. 2 W LIBERTY BLVD #100 MALVERN PA 19355 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 1.78 2023-02-25 4 A 0 185000 0.00 A 2033-02-24 Common Stock 185000 185000 D The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 25, 2023. /s/ Chris Degnan 2023-02-28